INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
Gene therapies been re-branded 'advanced therapies'—the feeding frenzy continues

Gene therapies been re-branded 'advanced therapies'—the feeding frenzy continues

Even FDAs top vaccine guy, Peter Marks, is in on it!

Hedley Rees's avatar
Hedley Rees
Sep 19, 2023
∙ Paid
18

Share this post

INSIDE PHARMA
INSIDE PHARMA
Gene therapies been re-branded 'advanced therapies'—the feeding frenzy continues
11
1
Share

Keep getting this advanced therapy conference in my mailbox

Every few weeks, I get an email from Terrapinn, asking me to buy a ticket for their 2024 conference on advanced therapies. The speaker list is below:

Advanced Therapies 2024, 19-20th March, ExCeL London

Scroll down to speakers with the name beginning with ‘M’, and you will see Peter Marks M.D., PhD., Director - Center for Biologics Evaluation and Research (CBER) .

Marks is the person with delegated authority to evaluate and research applications to market new biologics drugs, eg vaccines.

Could this just be a teenty weeny conflict of interest?

Not at all, it’s a massive one!!!

It is also unprecedented for someone in his position to do anything other than fly-in for a Keynote Address, then fly out again. Hobobbing with the regulated was always a no-no.

What about the other speakers?

Now check out the other speakers. Take it from me, none of them have a clue about the complexities of manufacturing and distributing complex biologic pro…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share